Healthequity Return on Average Assets Over Time

HQY
 Stock
  

USD 60.65  0.10  0.16%   

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please check Healthequity Performance and Healthequity Correlation.
  
Healthequity Average Assets are fairly stable at the moment as compared to the past year. Healthequity reported Average Assets of 3.13 Billion in 2021. Average Equity is likely to rise to about 2 B in 2022, whereas Return on Average Assets are likely to drop (0.0144)  in 2022.
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Return on Average Assets Analysis

Compare Healthequity and related stocks such as La-Z-Boy, Chevron Corp, Home Depot, JP Morgan Chase, 3M Company, Verizon Communications, Caterpillar, Pfizer Inc, and Alcoa Corp Return on Average Assets Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
LZB0.0640.0640.0640.0640.0640.0640.0640.0640.0640.0640.0640.080.0776
CVX0.1330.1330.1170.0870.0730.017(0.002)0.0360.0580.012(0.024)0.0650.0561
HD0.1510.1510.1510.1510.1510.2170.2170.2170.2170.2170.2280.2280.2253
JPM0.0080.0080.0090.0070.0080.0090.0090.0090.0120.0130.0080.0130.0124
MMM0.1350.1350.1330.1380.1510.1510.1520.1380.1430.1090.1180.1240.1232
VZ1.13981.06730.3844.60513.79837.4915.370912.00865.94976.92295.85366.46055.5424
CAT0.0660.0660.0650.0440.0290.031(0.001)0.010.0780.0780.0390.080.0694
PFE4.04795.22647.795612.29565.35194.13384.255712.40966.73459.95565.977913.094814.1289
AA(0.049)(0.049)(0.049)(0.049)(0.049)(0.049)(0.024)0.0160.015(0.074)(0.012)0.0290.0313

Healthequity and related stocks such as La-Z-Boy, Chevron Corp, Home Depot, JP Morgan Chase, 3M Company, Verizon Communications, Caterpillar, Pfizer Inc, and Alcoa Corp Return on Average Assets description

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].

My Equities

My Current Equities and Potential Positions

AMN - USA Stock
Amn Healthcare Services
AMN
Amn Healthcare Fama & French Business Services
Business Services
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
USD 113.8
Please check Healthequity Performance and Healthequity Correlation. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.